HOME >> MEDICINE >> NEWS
Implantable defibrillators cost-effective for preventing sudden death

collected on a subgroup of 237 patients, who were a balanced representation of the larger trial, geographically and medically.

We called these the shoebox patients, because we told them we wanted all their bills just bring them in a shoebox, says Larsen. The researchers converted the charges to 1997 costs. Three-year survival data from AVID were used to calculate the base cost effectiveness (C/E ratio). Six-year, 20-year and lifetime C/E ratios were also estimated.

The researchers determined that the largest expense for these patients is inpatient care, which makes up between 73 percent of total costs for drug therapy patients and 84 percent for ICD patients. At three years, the cost for the drug treatment group was $71,421. For the defibrillator group it was $85,522. The ICD provided a 0.21-year average survival benefit, putting the cost-effectiveness ratio at $66,677 per year of life saved.

The defibrillator patients lived longer, but they paid extra to get that extra life. The ratio of the additional amount paid for the additional survival benefit is the cost-effectiveness number, Larsen says.

According to Larsen, the conventional wisdom about cost-effectiveness ratios is that something is a bargain below about $50,000 per year of life saved, so the defibrillator is just on the margin of that bargain. Its on the high side but not out of reason.

The researchers also found that six- and 20-year C/E ratios remained stable between $68,000 and $80,000 per year of life saved.

This is only the beginning when it comes to cost-effectiveness studies on the devices, Larsen says. The cost effectiveness issue is going to be a very big part of the defibrillator story during the next year or two as more and more people look to ICDs for treatment.

For example, there may be changes in some of the big expenses from the ICD group, such as how often the ICD battery may need to be replaced, he says. At three
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
15-Apr-2002


Page: 1 2 3

Related medicine news :

1. Implantable heart defibrillators
2. Statement: Implantable medical identification chip
3. Implantable cardiac defibrillator use significantly lowers heart failure mortality
4. Implantable device pumps up ailing heart
5. Implantable heart device reduces deaths by one-third
6. Implanted defibrillators cut heart patients death risk, some more than others
7. Implanted defibrillators not covered for half of patients who could benefit, study finds
8. More doubts over value of defibrillators
9. One use every seven years makes automated external defibrillators a good buy
10. Benefit of public defibrillators is marginal
11. Health and fitness facilities need defibrillators

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... Grove Village, IL (PRWEB) , ... January 16, ... ... and personal audio products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs ... and Convention Center in Las Vegas, Booth #2809. The SHOT Show is the ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s fastest growing ... MD to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, ... a division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, ...
(Date:1/16/2017)... , ... January 16, 2017 , ... St. Louisans are well-aware of the following facts ... This year’s influenza shot seems to be having no effect on keeping this particularly ... half of the people around are coughing, sneezing, or sniffling , These ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types of ... test for, as well. The money spent screening for and treating cancer in the ... screen patients for cancer more than in any other country that has an advanced ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , January 17, 2017 ... 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... recently in European Neurological Review ... Catherine Amey reports that despite standard ...
(Date:1/17/2017)... January 17, 2017 Transparency Market Research has ... Acid, Sodium Benzoate, Benzyl Alcohol and Others) Market - Global Industry ... report, the global benzaldehyde derivative market was valued at ... 2.14 Bn by 2024, expanding at a CAGR of 5.1 % ... ...
(Date:1/17/2017)... DUBLIN and BUDAPEST, Hungary , ... ) and Gedeon Richter Plc. today announced positive results from ... trials evaluating the efficacy and safety of ulipristal acetate in ... drug application filing for ulipristal acetate is planned for the ... the favorable results of Venus II supporting the efficacy and ...
Breaking Medicine Technology:
Cached News: